National
Gay New Yorker in tight race with GOP incumbent
Maloney seeks to oust Hayworth; race a ‘tossup’
U.S. House candidate Sean Patrick Maloney (Blade photo by Michael Key)
Sean Patrick Maloney has ambitious goals for someone in a tight race seeking his first term in Congress. His priorities upon taking office would be “getting Congress working for people who need it working in their lives.”
“I think the most important thing right now is that too many voices aren’t being heard in Congress — the middle class, working people and people who care about equality, care about a future where we all count, we all work together,” Maloney said.
He’s seeking to unseat freshman Rep. Nan Hayworth (R-N.Y.) to represent New York’s 18th congressional district.
Maloney, who if elected would be the first openly gay member of Congress from New York, touted his previous work in Washington. He was a senior West Wing adviser in the Clinton administration and was first deputy secretary for former New York Gov. Eliot Spitzer.
“I know my way around Washington, and I’ve spent years working on different types of policies and partnerships in people in state government, people in local government, with the private sector,” Maloney said. “And so, I think I bring a set of relationships to the job that is unique for a freshman member, and a degree of experience in how Washington works when it’s working well.”
While he acknowledged the importance of having a Democratic majority in the U.S. House that “cares about LGBT people,” Maloney said he sees an opportunity for passage of pro-LGBT legislation even if Republicans remain in power — provided what he called the “extreme wing” of the party isn’t in control.
Maloney said New York could serve as an example because marriage equality legislation was passed in a Republican-controlled Senate under the leadership of Gov. Andrew Cuomo. The House candidate took credit for helping draft the New York marriage equality bill under the Spitzer administration, but said he wasn’t involved in the process of moving the law through in 2011.
“New York is the example,” Maloney said. “New York is where Democrats and Republicans have figured out how to work together on issues of LGBT equality. We don’t — look, you’ll never get everybody, but I do believe the day is coming when moderate voices, people who care about equality within the Republican Party will begin working with those of us who have been fighting for years on these issues.”
National LGBT groups are backing Maloney in pursuit of his U.S. House seat, including the Human Rights Campaign and the Gay & Lesbian Victory Fund.
Michael Cole-Schwartz, a spokesperson for the Human Rights Campaign, said his organization is working to help Maloney win.
“Sean Patrick Maloney is a wonderful candidate and will be a tremendous leader in the House,” Cole-Schwartz said. “HRC is committed to helping him win and we’re encouraging our members to support his campaign through our candidate fundraising tool at www.hrc.org/candidates.”
Maloney said he supports pro-LGBT legislation that Congress has yet to pass — including the Uniting American Families Act and the Employment Non-Discrimination Act — in addition to repeal of the Defense of the Marriage Act.
“I think a lot of us hope that the Supreme Court will establish as it did in the area of interracial marriage that denying equal marriage rights to same-sex couple is a violation of the federal Constitution as applied to the states, and so you’ll get a national constitution grounding for marriage,” Maloney said. “But Congress certainly has a role to play. We absolutely should repeal DOMA.”
Maloney also called on President Obama to revisit the idea of issuing an executive order that would bar federal contractors from discriminating in the workplace against LGBT people, saying the White House announcement in April that the order wouldn’t happen at this time “was a mistake.”
“I was disappointed that the White House made that decision,” Maloney said. “And I say that as someone who gives the president a great deal of credit for the position he took on marriage, which was historic, and for putting marriage equality front and center at the Democratic National Convention.”
Maloney lives in Cold Springs, N.Y. He has been with his partner, Randy Florke, a Realtor, since 1992 and they have three children: Jesús, Daley, and Essie. They also have homes in Sullivan County and New York City.
Rep. Nan Hayworth attends the 2012 Log Cabin annual dinner (Blade photo by Michael Key)
The contest to represent New York’s 18th congressional district is tight. Polls in recent weeks have showed Maloney running even with Hayworth, or slightly behind. A Public Policy Polling survey published Sept. 21 found Maloney and Hayworth both receiving 43 percent of support, while 14 percent were undecided.
Jessica Taylor, a senior analyst for the Rothenberg Political Report, ranked the race as a “pure toss-up” because even though being an incumbent would give her an advantage, Hayworth won her seat in a good Republican year, and the district is generally Democratic and would probably see more Democratic turnout in the presidential election.
“I think it’s going to be a really close battle,” Taylor said. “Her first ad against Maloney hits him on how he just moved into the district. I think that could be an effective strategy, but also, this is not a new thing for New York — people first living in the city and moving out to the suburban areas.”
During the Blade interview, Maloney criticized Hayworth, calling her “one of the most extreme members of Congress” and saying she’s “out of step with her district” for supporting legislation put forward by House Republican leaders.
“She wants to end Medicare and give massive tax cuts to multi-millionaires like herself,” Maloney said. “She wants to defund Planned Parenthood. She wants to deny women access to contraception. … On issue after issue that is important to LGBT equality, that is important to the middle class that is important to women’s rights and women’s health, she has been an extreme conservative.”
But Hayworth has a fairly good record on LGBT issues during her first term in Congress. A member of the LGBT Equality Caucus, Hayworth voted against three amendments on the House floor that reaffirmed the Defense of Marriage Act. She’s also a co-sponsor of ENDA and the Domestic Partner Tax Parity Act, which would end the tax penalty by individuals who receive health insurance for their partners from their employers.
R. Clarke Cooper, executive director of the Log Cabin Republicans, praised Hayworth’s action on LGBT issues upon taking her House seat. The organization as of Tuesday hasn’t endorsed Hayworth.
“When Nan Hayworth came to Congress as a freshman in 2011, she quickly distinguished herself by becoming Deputy Majority Whip and joining the bi-partisan LGBT Equality Caucus,” Cooper said. “Her active presence among her peers in the House and within the House Republican leadership is critical to advancing equality, restoring fiscal discipline and maintaining a majority in the Congress.”
Will Hayworth (Blade photo by Michael Key)
Hayworth has a gay son, Will Hayworth, who lives in D.C. According to his website, he studied economics and computer science at Bard College and has experience as a research intern covering monetary policy at libertarian think-tank called the Cato Institute. He identifies as “a registered Republican with very, very libertarian leanings.”
But Maloney was unimpressed with Hayworth’s actions and called on her to articulate her position on marriage equality — which he said 60 percent of his district supports — and say whether she wants to repeal DOMA.
“It’s real simple,” Maloney said. “All she has to do is say she supports marriage equality and repeal of DOMA. She won’t. So, talk is cheap, procedural votes are cheap. When the rubber meets the road, she is not our friend. She is terrible on LGBT equality and I’ve been working on these issues for 20 years of my life. So, I would invite her to — and you should ask her — does she support marriage equality? Will she support the repeal of DOMA? She won’t. I will. That’s the choice.”
The Blade attempted to speak with the Republican lawmaker during the Log Cabin’s “Spirit of Lincoln” awards dinner in D.C. on Sept. 20 — which she attended with her son Will Hayworth — about her position on marriage equality and DOMA, but she refused to take questions. Requests to comment for this article weren’t returned by Hayworth’s campaign or her office.
Maloney said he’s aware Hayworth has a gay son. Asked whether that heightens the need for her to address her positions on LGBT issues, Maloney replied, “All that we have is her record, and she will not say that she supports marriage equality and she will not support the repeal of DOMA. Why she believes that, what she really believes, you’ll have to ask her. I’m not qualified to speak to anything other than what her record is as a member of Congress. And her record is terrible for the most important issue for our community: She is not our friend on marriage equality.”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
‘Dogs of Venice’ looks at love lost and rediscovered
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
Comings & Goings
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Lighting candles in a time of exhaustion
Why queer spaces often fail South Asian women
